Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Marathon Petroleum Corp (MPC) vs Smith & Nephew plc (SNN) Price & Performance

Marathon Petroleum CorpTrade
Smith & Nephew plcTrade

Price performance (Past 24H)

Key statistics

Marathon Petroleum Corp vs Smith & Nephew plc — how do they compare? Marathon Petroleum Corp trades at $462.2 (market cap $124.20B), while Smith & Nephew plc trades at $26.9 (market cap $11.31B). The key difference: Marathon Petroleum Corp is far larger — about 11× Smith & Nephew plc's market cap, and Smith & Nephew plc pays the higher dividend (2.95%). Which is the better fit depends on your goals — on Pluang, investors hold Marathon Petroleum Corp for 54 Days and Smith & Nephew plc for 120 Days on average.

MPCSNN
Market Cap
$124.20B$11.31B
Volume
1,923,3731,050,005
Sector
EnergyHealth
52-Week High
$463.34$37.17
52-Week Low
$162.63$26.42
Typical Hold Time
54 Days120 Days
Enterprise Value
$150.72B$14.35B
Dividend Yield
0.9%2.95%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Marathon Petroleum Corp

Marathon Petroleum (MPC) trades at $463.34, up 7.17% over 24 hours and near its 52-week high. The stock exhibits strong bullish momentum with consistent earnings beats and robust profitability metrics, including a 47.9% ROE. Recent news highlights refining margin strength amid tight global capacity, though potential diesel export curbs pose a risk. Technical indicators show bullish moving averages but an overbought RSI, with key resistance at $452.

MPC presents a compelling investment case with solid fundamentals, high analyst buy ratings (75.76%), and a consensus price target of $420.30. Upside is driven by elevated refining margins and earnings growth, but risks include regulatory threats to exports and volatile energy markets. The stock's current premium to target suggests cautious optimism amid near-term overbought conditions.

Smith & Nephew plc

SNN trades at $26.96, near its 52-week low, with a bearish technical signal. The company has shown improving fundamentals, with revenue growing from $5.2B in 2022 to $6.16B in 2025 and net income margin expanding to 10.08%. Recent product launches, like the EVOS PELVIC System, highlight innovation, but the stock faces negative sentiment from analyst downgrades and CFO departure news.

The outlook is mixed: strong profitability and cash flow support value, but bearish technicals and cautious analyst consensus (26% buy, 65% hold) suggest limited near-term upside. Key risks include execution challenges and competitive pressures. Investors should weigh solid fundamentals against weak market sentiment.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MPC
49% Buy51% Sell
Avg holding period · 54 Days
SNN

No sentiment data available yet.

Top news

Latest headlines on both assets

About Marathon Petroleum Corp

Marathon Petroleum is an independent refiner with 13 refineries in the midcontinent, West Coast, and Gulf Coast of the United States with total throughput capacity of 2.9 million barrels per day. Its Dickinson, ND, facility produces 184 million gallons a year of renewable diesel. Its Martinez, CA, facility will have the ability to produce 730 million gallons a year of renewable diesel once converted. The firm also owns and operates midstream assets primarily through its listed MLP, MPLX.

Read more on MPC →

About Smith & Nephew plc

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Read more on SNN →